NCT04084314 - Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study | Biotech Hunter

Enrollment

701

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

February 23, 2023

Study Completion Date

March 13, 2023

Conditions

MigraineMigraine DisordersMigraine Headache

Interventions

BIOLOGICAL

Erenumab

Erenumab was supplied as a pre-filled pen (auto-injector) for subcutaneous injection.

Trial Locations (75)

10713

Novartis Investigative Site, Berlin

12101

Novartis Investigative Site, Berlin

12163

Novartis Investigative Site, Berlin

12627

Novartis Investigative Site, Berlin

13053

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

14169

Novartis Investigative Site, Berlin

15366

Novartis Investigative Site, Hoppegarten

15526

Novartis Investigative Site, Bad Saarow

17475

Novartis Investigative Site, Greifswald

18057

Novartis Investigative Site, Rostock

19053

Novartis Investigative Site, Schwerin

19055

Novartis Investigative Site, Schwerin

20253

Novartis Investigative Site, Hamburg

24149

Novartis Investigative Site, Kiel

26655

Novartis Investigative Site, Westerstede Oldenburg

30159

Novartis Investigative Site, Hanover

34121

Novartis Investigative Site, Kassel

35041

Novartis Investigative Site, Marburg Wehrda

38723

Novartis Investigative Site, Seesen

44534

Novartis Investigative Site, Lünen

44791

Novartis Investigative Site, Bochum

45133

Novartis Investigative Site, Essen

45147

Novartis Investigative Site, Essen

45879

Novartis Investigative Site, Gelsenkirchen

48149

Novartis Investigative Site, Münster

49074

Novartis Investigative Site, Osnabrück

49477

Novartis Investigative Site, Ibbenbueren

49610

Novartis Investigative Site, Quakenbrück

50935

Novartis Investigative Site, Cologne

52062

Novartis Investigative Site, Aachen

52428

Novartis Investigative Site, Jülich

53111

Novartis Investigative Site, Bonn

53177

Novartis Investigative Site, Bonn

53604

Novartis Investigative Site, Bad Honnef

54292

Novartis Investigative Site, Trier

57076

Novartis Investigative Site, Siegen

60313

Novartis Investigative Site, Frankfurt

61348

Novartis Investigative Site, Bad Homburg

61462

Novartis Investigative Site, Königstein im Taunus

63755

Novartis Investigative Site, Alzenau in Unterfranken

64711

Novartis Investigative Site, Erbach im Odenwald

65191

Novartis Investigative Site, Wiesbaden

66163

Novartis Investigative Site, Mannheim

66763

Novartis Investigative Site, Dillingen

69120

Novartis Investigative Site, Heidelberg

70174

Novartis Investigative Site, Stuttgart

70178

Novartis Investigative Site, Stuttgart

70182

Novartis Investigative Site, Stuttgart

71032

Novartis Investigative Site, Böblingen

71065

Novartis Investigative Site, Sindelfingen

72076

Novartis Investigative Site, Tübingen

75172

Novartis Investigative Site, Pforzheim

76761

Novartis Investigative Site, Rülzheim

79098

Novartis Investigative Site, Freiburg im Breisgau

81377

Novartis Investigative Site, München

81675

Novartis Investigative Site, München

82008

Novartis Investigative Site, Unterhaching

85540

Novartis Investigative Site, Haar

86633

Novartis Investigative Site, Neuburg an der Donau

89073

Novartis Investigative Site, Ulm

89231

Novartis Investigative Site, Neu-Ulm

93059

Novartis Investigative Site, Regensburg

95445

Novartis Investigative Site, Bayreuth

97080

Novartis Investigative Site, Würzburg

120999

Novartis Investigative Site, Berlin

D 33647

Novartis Investigative Site, Bielefeld

09117

Novartis Investigative Site, Chemnitz

06120

Novartis Investigative Site, Halle

07740

Novartis Investigative Site, Jena

04103

Novartis Investigative Site, Leipzig

04107

Novartis Investigative Site, Leipzig

09648

Novartis Investigative Site, Mittweida

07646

Novartis Investigative Site, Stadtroda